Turi-Med, Turinabol, 10 mg, 120 Tabs

TURI-MED 10 mg by Bioniche Pharma contains 4-Chlorodehydromethyltestosterone (Oral Turinabol), an orally bioavailable derivative of Methandrostenolone modified with a 4-chloro substitution. Formulated by Bioniche Pharma to deliver balanced anabolic activity, Bioniche Pharma TURI-MED promotes steady, high-quality skeletal muscle tissue accretion and strength development without converting into estrogen through aromatization.

CLINICAL PHARMACOLOGY & MECHANISM OF ACTION

4-Chlorodehydromethyltestosterone in Bioniche Pharma TURI-MED functions through high-affinity binding to intracellular androgen receptors, driving positive nitrogen conservation and accelerating skeletal muscle protein synthesis. Owing to its structural 4-chloro modification, TURI-MED by Bioniche Pharma is entirely resistant to the aromatase enzyme, preventing estrogenic complications such as subcutaneous fluid retention, water accumulation, and gynecomastia.

INDICATIONS & CLINICAL USE

• Therapeutic support in conditions requiring gradual, sustained lean tissue buildup and recovery from catabolic muscle-wasting states under professional medical supervision.
• Adjunctive management during clinical rehabilitation following severe physical trauma, post-surgical debilitation, or chronic wasting conditions using Bioniche Pharma formulations.

CONTRAINDICATIONS

• Male patients presenting with diagnosed or suspected prostate carcinoma or male breast cancer.
• Female breast carcinoma complicated by hypercalcemia, as androgenic anabolic steroids can stimulate osteolytic bone resorption.
• Pregnancy and nursing due to severe risks of fetal virilization, structural developmental abnormalities, and systemic endocrine disruption.
• Known hypersensitivity or allergic response to 4-Chlorodehydromethyltestosterone or inactive compounding excipients in Bioniche Pharma preparations.

ADVERSE REACTIONS & PRECAUTIONS

Adverse events associated with Bioniche Pharma TURI-MED administration are typically dose-dependent and gender-specific:

• Endocrine & Reproductive: Reversible suppression of the endogenous pituitary-testicular axis and natural testosterone production in male patients. Female patients carry a risk of virilization symptoms (including voice deepening, facial/body hirsutism, and clitoral hypertrophy) if recommended thresholds or administration durations for Bioniche Pharma TURI-MED are exceeded.
• Hepatic & Metabolic Strain: As a $17\alpha$-alkylated oral formulation, periodic laboratory evaluation of hepatic transaminases and serum lipid panels (elevation of LDL, reduction of HDL) is strongly indicated during Bioniche Pharma TURI-MED therapy.
• Dermatological, Gastrointestinal & Behavioral: Occasional development of acne vulgaris, gastrointestinal upset or nausea, and potential shifts in mood or aggression. Fluctuations in libido have also been reported in both male and female patients during treatment.

DOSAGE & ADMINISTRATION

Dosing protocols for TURI-MED by Bioniche Pharma should be individually calculated and monitored under direct medical direction, taking into consideration clinical goals, gender, and diagnostic laboratory panels.

STORAGE & HANDLING

Store Bioniche Pharma TURI-MED in a dry, cool environment protected from direct light exposure, elevated temperatures, and excess moisture. Keep strictly out of the reach and sight of children.